Search

Your search keyword '"Cresols adverse effects"' showing total 5 results

Search Constraints

Start Over You searched for: Descriptor "Cresols adverse effects" Remove constraint Descriptor: "Cresols adverse effects" Journal european urology Remove constraint Journal: european urology
5 results on '"Cresols adverse effects"'

Search Results

1. Long-term tolerability of tolterodine extended release in children 5-11 years of age: results from a 12-month, open-label study.

2. Editorial comment on: Long-term tolerability of tolterodine extended release in children 5-11 years of age: results from a 12-month, open-label study.

Catalog

Books, media, physical & digital resources

3. Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.

4. Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 2005;48:464-70.

5. Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review.